ong-term efficiacy of intrathecal opioid therapy

• Conditions: chronic pain patients carrying an intrathecal opioid pump/ efficiacy of the therapyand unwanted side-effects of the intrathecal opioid therapy; R52.2; Other chronic pain

• Registration Number: DRKS00014019
• Lead Sponsor: Interdisziplinäres Schmerzzentrum, UKL Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-08-01
• Study Start: 2018-02-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

intrathecal opioid application via medication pump for at least five years
ability to understand and fill in the questionnaire

Exclusion Criteria

severe psychiatric comorbidity (i.e. severe depression)
linguistic or cognitive incapacity to fill in the questionnaire

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain rating on the NRS, recorded from the patients charts and from the questionnaire

Secondary Outcome Measures

Name	Time	Method
side-effects of the intrathecal opioid therapy and further pain-relevant parameters such as life quality, anxiety/depression, sleep, quality and satisfaction with intrathecal opioid therapy, recorded from the questionnaire